VeriMomБезопасен ли oligopeptide-55 при беременности?
No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
Related ingredients
Frequently asked questions
- Безопасен ли oligopeptide-55 при беременности?
- No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
- Безопасен ли oligopeptide-55 при грудном вскармливании?
- No data indicating lactation transfer or effects on nursing infants. No classifications or published evidence of systemic reproductive/endocrine activity. Given expected low dermal absorption for oligopeptides, systemic exposure to nursing parent is expected to be negligible for typical topical cosmetic use.
- Безопасен ли oligopeptide-55 для кожи малыша?
- No evidence of hazard or mechanism specific to infants. Dermal absorption of intact oligopeptides is generally low, but infant skin has immature barrier and higher surface-area-to-weight; therefore exposure (e) is increased by one category relative to adults (adult e=0 → baby e=1) despite no hazard data. No infant-specific studies were found.
- Как VeriMom оценивает oligopeptide-55?
- VeriMom оценивает oligopeptide-55 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы oligopeptide-55 при беременности?
- См. наш список безопасных альтернатив oligopeptide-55 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.